NervGen Pharma Grants Stock Options

Vancouver, Canada. July 16, 2021 – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to creating innovative solutions for the treatment of nervous system damage, today announced that the Company has granted 125,000 incentive stock options to existing consultants providing investor relations services, 25,000 of which […]

NervGen Pharma Establishes Multiple Sclerosis Clinical Advisory Board / NervGen Supports World Brain Day on July 22 to “Stop Multiple Sclerosis”

Vancouver, Canada. July 15, 2021 – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to creating innovative solutions for the treatment of nervous system damage, today announced the formation of its Multiple Sclerosis (MS) Clinical Advisory Board comprised of six world-class scientific and clinical researchers in […]

The Outdoor Diaries: Andy McKenna, Multiple Sclerosis and Mountain Biking

By Codi Darnell July 20, 2021 Welcome to our blog series: The Outdoor Diaries. This series is about exploring the natural world from the perspective of people with chronic conditions and/or mobility issues. While the benefits of nature are for everybody, access to it isn’t always quite as simple. There is nothing like a diagnosis […]

NervGen Pharma Expands Alzheimer’s Disease Scientific Advisory Board

Vancouver, Canada. July 12, 2021 – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to creating innovative solutions for the treatment of nervous system damage, today announced the addition of three world-class scientists and clinical researchers to its Alzheimer’s Disease Scientific Advisory Board. Drs. Martin Farlow, […]

One Year of Stroke Recovery

By Codi Darnell July 6, 2021 There are many ways we humans mark the passing of another year – birthdays, anniversaries, and the actual shift of the calendar on New Year’s Eve, just to name just a few. These celebrations frequently pass with reflections of the lives we lived in the previous 365 days, days […]

NervGen Engages Vorticom Inc. to Provide Media Relations Services

Vancouver, Canada. June 25, 2021 – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to creating innovative solutions for the treatment of nervous system damage, announced that it has engaged Vorticom Inc. (“Vorticom”), a New York based full-service public relations agency to provide media relations and […]

The Outdoor Diaries: Rediscovering a Love of the Ocean – A Story of Adapted Surfing

By Codi Darnell June 22, 2021 Welcome to our blog series: The Outdoor Diaries. This series is about exploring the natural world from the perspective of people with chronic conditions and/or mobility issues. While the benefits of nature are for everybody, access to it isn’t always quite as simple. Imagine your favourite place – the […]

NervGen Pharma Enters into Research Agreement with Sylics to Study NVG-291 in Alzheimer’s Disease Models / NervGen Preparing for Upcoming Phase 1b Clinical Trial in Alzheimer’s Disease

Vancouver, Canada. June 10, 2021 – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to creating innovative solutions for the treatment of nervous system damage, announced today it has entered into a research agreement with Sylics Contract Research (“Sylics”), a contract research organization specializing in testing […]

Life, Love and Alzheimer’s – A Daughter’s Perspective

By Codi Darnell June 8, 2021 The dynamic of a child-parent relationship is one that shifts many times over a lifetime. It twists and turns as children become adults and parents go from hero to human. It’s in your twenties when you start to discover who your parents are as people beyond their Mom and […]